Geron reported $-13.89M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Amgen USD 3.96B 464M Dec/2025
Bio Techne USD 47.66M 71.52M Sep/2025
Cassava Sciences USD -11.86M 33.53M Sep/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
Exelixis USD 256.36M 42.78M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
Geron USD -13.89M 1.43M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
MacroGenics USD 20.16M 55.51M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025